MMWR Morb Mortal Wkly Rep. 2016 May 6;65(17):438-42. doi: 10.15585/mmwr.mm6517a3.
In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan (GVAP)* with the objective to eliminate measles and rubella in five World Health Organization (WHO) regions by 2020. In September 2013, countries in all six WHO regions had established measles elimination goals, and additional goals for elimination of rubella and congenital rubella syndrome were established in three regions (1). Capacity for surveillance, including laboratory confirmation, is fundamental to monitoring and verifying elimination. The 2012-2020 Global Measles and Rubella Strategic Plan of the Measles and Rubella Initiative(†) calls for effective case-based surveillance with laboratory testing for case confirmation (2). In 2000, the WHO Global Measles and Rubella Laboratory Network (GMRLN) was established to provide high quality laboratory support for surveillance (3). The GMRLN is the largest globally coordinated laboratory network, with 703 laboratories supporting surveillance in 191 countries. During 2010-2015, 742,187 serum specimens were tested, and 27,832 viral sequences were reported globally. Expansion of the capacity of the GMRLN will support measles and rubella elimination efforts as well as surveillance for other vaccine-preventable diseases (VPDs), including rotavirus, and for emerging pathogens of public health concern.
2012 年，世界卫生大会通过了《全球疫苗行动计划》（GVAP）*，目标是到 2020 年在世界卫生组织（WHO）的五个区域消除麻疹和风疹。2013 年 9 月，所有六个世卫组织区域的国家都制定了消除麻疹的目标，并在三个区域（1）制定了消除风疹和先天性风疹综合征的额外目标。监测能力，包括实验室确认，是监测和核实消除情况的基础。麻疹和风疹倡议（†）的 2012-2020 年全球麻疹和风疹战略计划呼吁进行有效的基于病例的监测，并进行实验室检测以确认病例（2）。2000 年，世卫组织全球麻疹和风疹实验室网络（GMRLN）成立，为监测提供高质量的实验室支持（3）。GMRLN 是全球最大的协调实验室网络，有 703 个实验室支持 191 个国家的监测工作。在 2010-2015 年期间，共检测了 742,187 份血清样本，全球报告了 27,832 份病毒序列。GMRLN 能力的扩大将支持麻疹和风疹的消除工作以及其他疫苗可预防疾病（VPDs）的监测，包括轮状病毒以及对公共卫生关注的新出现病原体的监测。
